All In MedTech

Device Trial Radar · NCT04315415

A Histological Study Evaluating Silk Voice and Crosslinked Hyaluronic Acid

Last checked: Nov 20, 2026Latest source record: Apr 20, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

14

Actual

Start

Jan 15, 2020

Primary completion

Feb 17, 2022

Study completion Apr 18, 2022

Sponsor

Lead sponsor
Sofregen Medical, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Mar 19, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Basic science
FDA-regulated device
Yes
Who can join
All sexes, from 22 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The primary study goal is to evaluate the histological characteristic of Silk Voice to evaluate the potential for Silk Voice to deliver long-term results to patients.

Conditions

  • Vocal Fold Palsy
  • Vocal Cord Paralysis
  • Vocal Cord Atrophy

Interventions

  • Silk VoiceDevice

    Silk Voice comprised of silk protein and cross-linked hyaluronic acid (HA)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of subjects exhibiting histological evidence of newly deposited tissue compared to control implantation.Time frame: 6 month
  2. Number of subjects exhibiting histological evidence of newly deposited tissue compared to control implantation.Time frame: 12 month
  3. Number of subjects exhibiting histological evidence of newly deposited tissue compared to control implantation.Time frame: 24 month

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • DeNova Research

    Chicago, Illinois

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.